IAS 2025, the 13th IAS Conference on HIV Science, returns the conference to the African continent, which is at the heart of the HIV response. IAS 2025 will highlight the latest science, innovation and frontline efforts in addressing HIV in Africa and across the world.
The withdrawal of US funding for HIV programmes is a global public health crisis. US investments have driven scientific breakthroughs, life-saving treatments and prevention efforts worldwide. We must work together to avoid losing the many gains made to date and chart a new and equitable path forward.
Against this backdrop, IAS 2025 will focus on these key objectives:
Objective 1
Highlight the latest advancements in HIV science, with a particular focus on showcasing the significant contributions of African scientists in addressing the epidemic on the continent most affected by HIV.
Objective 2
Establish a legacy of research, ranging from basic science to implementation science, that is responsive to the priorities of affected communities and led by those most impacted.
Objective 3
Accelerate innovation in basic and clinical science for person-centred precision medicine for HIV, encompassing research on reducing transmission, developing vaccines, understanding pathogenesis, managing co-infections and co-morbidities, addressing ageing-related issues, and advancing toward an HIV cure.
Objective 4
Strengthen HIV prevention research to optimize cost-effective biomedical, behavioural and structural interventions, with a focus on identifying and overcoming implementation challenges, dismantling system barriers, and scaling successful prevention strategies in practice.
Objective 5
Promote interdisciplinary collaboration across biomedical, clinical, social and implementation sciences to improve HIV outcomes across all life stages, with a strong focus on translating research findings into actionable policies and practices.